SEC Form 4/A · accession 0001140361-17-010771
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Rebecca M Henderson
Director
Period of report
Aug 25, 2016
Accepted (ET)
Mar 6, 2017 · 6:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 25, 2016 | M | 9,924 | $26.655 | A | 31,374 | D | |
| Common StockF1 | Aug 25, 2016 | S | 9,924 | $110.4346 | D | 21,450 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy)F3,F2 | $26.655 | Aug 25, 2016 | M | 9,924 | D | — | Feb 13, 2017 | Common Stock | 9,924 | 0 | D |
Explanation of responses
- F1This Form 4 is being amended solely to correct the number of shares of common stock beneficially owned by the reporting person following the reported transactions on the date of the transactions.
- F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,962 shares on February 14, 2011, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F3Not applicable.